Il Consiglio di Amministrazione di Philogen S.p.A., in data 27 Marzo 2024, ha approvato il Bilancio di Sostenibilità 2023 che rappresenta un documento organico di rendicontazione degli impatti, delle iniziative e delle...
Read moreManagement will host a 1-hour live webcast and conference call on April 3, 2024 at 10:00 ET / 15:00 BST / 16:00 CET. The presentation will be followed by a Q&A session. Please follow...
Read moreFollow the link here for more details
The Italian Midcap Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri and CFO Laura Baldi through a series of...
Read moreProf. Dr. Giuseppe Curigliano, on behalf of Philogen, is giving a presentation about the Phase I DODEKA study on February 26th, entitled “Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19)...
Read moreProf. Dario Neri, PhD, (CEO and CSO of Philogen) is giving a presentation entitled “Immunocytokines”.
Follow the link here for more details